Literature DB >> 28334147

Variations in Acetylcholinesterase Activity within Human Cortical Pyramidal Neurons Across Age and Cognitive Trajectories.

Monica Janeczek1, Tamar Gefen1, Mehrnoosh Samimi1, Garam Kim1, Sandra Weintraub1, Eileen Bigio1, Emily Rogalski1, M-Marsel Mesulam1, Changiz Geula1.   

Abstract

We described an extensive network of cortical pyramidal neurons in the human brain with abundant acetylcholinesterase (AChE) activity. Emergence of these neurons during childhood/adolescence, attainment of highest density in early adulthood, and virtual absence in other species led us to hypothesize involvement of AChE within these neurons in higher cortical functions. The current study quantified the density and staining intensity of these neurons using histochemical procedures. Few faintly stained AChE-positive cortical pyramidal neurons were observed in children/adolescents. These neurons attained their highest density and staining intensity in young adulthood. Compared with the young adult group, brains of cognitively normal elderly displayed no significant change in numerical density but a significant decrease in staining intensity of AChE-positive cortical pyramidal neurons. Brains of elderly above age 80 with unusually preserved memory performance (SuperAgers) showed significantly lower staining intensity and density of these neurons when compared with same-age peers. Conceivably, low levels of AChE activity could enhance the impact of acetylcholine on pyramidal neurons to counterbalance other involutional factors that mediate the decline of memory capacity during average aging. We cannot yet tell if elderly with superior memory capacity have constitutively low neuronal AChE levels or if this feature reflects adaptive neuroplasticity.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28334147      PMCID: PMC6059146          DOI: 10.1093/cercor/bhx047

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  49 in total

1.  Differential cholinergic innervation within functional subdivisions of the human cerebral cortex: a choline acetyltransferase study.

Authors:  M M Mesulam; L B Hersh; D C Mash; C Geula
Journal:  J Comp Neurol       Date:  1992-04-15       Impact factor: 3.215

2.  Learning impairments following injection of a selective cholinergic immunotoxin, ME20.4 IgG-saporin, into the basal nucleus of Meynert in monkeys.

Authors:  A Fine; C Hoyle; C J Maclean; T L Levatte; H F Baker; R M Ridley
Journal:  Neuroscience       Date:  1997-11       Impact factor: 3.590

3.  Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.

Authors:  Alaina Baker-Nigh; Shahrooz Vahedi; Elena Goetz Davis; Sandra Weintraub; Eileen H Bigio; William L Klein; Changiz Geula
Journal:  Brain       Date:  2015-03-01       Impact factor: 13.501

4.  Loss of calbindin-D28k from aging human cholinergic basal forebrain: relation to neuronal loss.

Authors:  Changiz Geula; Jing Bu; Nicholas Nagykery; Leonard F M Scinto; Jennifer Chan; Jeffrey Joseph; Robert Parker; Chuang-Kuo Wu
Journal:  J Comp Neurol       Date:  2003-01-06       Impact factor: 3.215

5.  Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.

Authors:  Jean C Augustinack; Anja Schneider; Eva-Maria Mandelkow; Bradley T Hyman
Journal:  Acta Neuropathol       Date:  2002-01       Impact factor: 17.088

6.  Cholinesterases regulate neurite growth of chick nerve cells in vitro by means of a non-enzymatic mechanism.

Authors:  P G Layer; T Weikert; R Alber
Journal:  Cell Tissue Res       Date:  1993-08       Impact factor: 5.249

7.  Chemoarchitectonics of axonal and perikaryal acetylcholinesterase along information processing systems of the human cerebral cortex.

Authors:  M M Mesulam; C Geula
Journal:  Brain Res Bull       Date:  1994       Impact factor: 4.077

8.  Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease.

Authors:  P V Arriagada; K Marzloff; B T Hyman
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

Review 9.  The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery.

Authors:  Sandra Weintraub; David Salmon; Nathaniel Mercaldo; Steven Ferris; Neill R Graff-Radford; Helena Chui; Jeffrey Cummings; Charles DeCarli; Norman L Foster; Douglas Galasko; Elaine Peskind; Woodrow Dietrich; Duane L Beekly; Walter A Kukull; John C Morris
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Apr-Jun       Impact factor: 2.703

10.  Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme.

Authors:  N C Inestrosa; A Alvarez; C A Pérez; R D Moreno; M Vicente; C Linker; O I Casanueva; C Soto; J Garrido
Journal:  Neuron       Date:  1996-04       Impact factor: 17.173

View more
  10 in total

1.  Understanding brain resilience in superagers: a systematic review.

Authors:  Laiz Laura de Godoy; Cesar Augusto Pinheiro Ferreira Alves; Juan Sebastian Martin Saavedra; Adalberto Studart-Neto; Ricardo Nitrini; Claudia da Costa Leite; Sotirios Bisdas
Journal:  Neuroradiology       Date:  2020-09-30       Impact factor: 2.804

2.  Paucity of Entorhinal Cortex Pathology of the Alzheimer's Type in SuperAgers with Superior Memory Performance.

Authors:  Tamar Gefen; Allegra Kawles; Beth Makowski-Woidan; Janessa Engelmeyer; Ivan Ayala; Payam Abbassian; Hui Zhang; Sandra Weintraub; Margaret E Flanagan; Qinwen Mao; Eileen H Bigio; Emily Rogalski; M Marsel Mesulam; Changiz Geula
Journal:  Cereb Cortex       Date:  2021-06-10       Impact factor: 4.861

Review 3.  Acetylcholine Neuromodulation in Normal and Abnormal Learning and Memory: Vigilance Control in Waking, Sleep, Autism, Amnesia and Alzheimer's Disease.

Authors:  Stephen Grossberg
Journal:  Front Neural Circuits       Date:  2017-11-02       Impact factor: 3.492

Review 4.  Operationalized definition of older adults with high cognitive performance.

Authors:  Wyllians Vendramini Borelli; Karoline Carvalho Carmona; Adalberto Studart-Neto; Ricardo Nitrini; Paulo Caramelli; Jaderson Costa da Costa
Journal:  Dement Neuropsychol       Date:  2018 Jul-Sep

Review 5.  Magnetic resonance imaging of brain cell water.

Authors:  Takashi Watanabe; Xiaoqing Wang; Zhengguo Tan; Jens Frahm
Journal:  Sci Rep       Date:  2019-03-25       Impact factor: 4.379

6.  Walnut Oil Prevents Scopolamine-Induced Memory Dysfunction in a Mouse Model.

Authors:  Jianqiao Liao; Yifan Nai; Li Feng; Yimeng Chen; Mei Li; Huaide Xu
Journal:  Molecules       Date:  2020-04-02       Impact factor: 4.411

Review 7.  Improving Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Are Irreversible Inhibitors the Future?

Authors:  Donald E Moss
Journal:  Int J Mol Sci       Date:  2020-05-13       Impact factor: 5.923

8.  Neuroprotective Effects of the Multitarget Agent AVCRI104P3 in Brain of Middle-Aged Mice.

Authors:  Julia Relat; Julio Come; Belen Perez; Pelayo Camps; Diego Muñoz-Torrero; Albert Badia; Lydia Gimenez-Llort; M Victòria Clos
Journal:  Int J Mol Sci       Date:  2018-09-04       Impact factor: 5.923

9.  Don't forget-Age is a relevant variable in defining SuperAgers.

Authors:  Emily Joy Rogalski
Journal:  Alzheimers Dement (Amst)       Date:  2019-08-12

Review 10.  Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance.

Authors:  Changiz Geula; Sara R Dunlop; Ivan Ayala; Allegra S Kawles; Margaret E Flanagan; Tamar Gefen; Marek-Marsel Mesulam
Journal:  J Neurochem       Date:  2021-08-06       Impact factor: 5.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.